Petra Kaufmann

Petra Kaufmann

Chief Tech/Sci/R&D Officer at OVID THERAPEUTICS INC.
60 year
Health Technology
Consumer Services
Government

Profile

Petra Kaufmann is currently Chief Medical Officer at Ovid Therapeutics, Inc. since 2025.
Former positions include Chief Medical Officer at Affinia Therapeutics, Inc. from 2021 to 2024, SVP, Head-Clinical Development & Analytics at Novartis Gene Therapies, Inc. from 2020 to 2021, Director-Rare Diseases Research at National Institutes of Health from 2015 to 2018, and Chief Medical Officer at Vigil Neuroscience, Inc. Education includes a graduate degree from The Trustees of Columbia University in The City of New York and a doctorate from the University of Bonn.

Petra Kaufmann active positions

CompaniesPositionStart
OVID THERAPEUTICS INC. Chief Tech/Sci/R&D Officer 2025-12-01

Former positions of Petra Kaufmann

CompaniesPositionEnd
Chief Tech/Sci/R&D Officer 2024-02-29
AVEXIS INC Corporate Officer/Principal 2021-01-31
Corporate Officer/Principal 2018-01-31
VIGIL NEUROSCIENCE, INC. Chief Tech/Sci/R&D Officer -
See the detail of Petra Kaufmann's experience

Training of Petra Kaufmann

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

51

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Consumer Services

Government

Consumer Services

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Petra Kaufmann